Schloss Wachenheim AG (LON:0G6J)

Market Cap	102.23M
Revenue (ttm)	373.47M
Net Income (ttm)	9.14M
Shares Out	n/a
EPS (ttm)	1.15
PE Ratio	11.19
Forward PE	10.78
Dividend	0.50 (3.39%)
Ex-Dividend Date	Nov 22, 2024

Volume	1
Average Volume	3
Open	14.70
Previous Close	n/a
Day's Range	14.70 - 14.70
52-Week Range	13.60 - 16.00
Beta	0.27
RSI	44.75
Earnings Date	Sep 26, 2025

About Theseus Pharmaceuticals

Schloss Wachenheim AG produces and distributes sparkling and semi-sparkling wine products in Europe and internationally. The company provides dealcoholized sparkling wines and wines, vermouth, cider, spirits, and other wine-based drinks. It also offers alcohol-free children's drinks. The company markets its products under the Light Live, Faber, Robby Bubble, Schloss Wachenheim, Nymphenburg Sekt, Schweriner Burggarten, Schwansee Sket, Bar Royal, Eisberg, Kleine Reblaus, Rebling, Schloss Bochingen, Feist, Azzurro, Blû Prosecco, Premiat, Mädchentr...

• Industry: Wines, Brandy, and Brandy Spirits
• Founded: 1888
• Employees: 1,700
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0G6J

Financial Performance

In 2024, Schloss Wachenheim AG's revenue was 441.51 million, an increase of 3.70% compared to the previous year's 425.75 million. Earnings were 9.47 million, a decrease of -13.13%.